Cited by 169Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and Management

In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry

Open access
Targher, Giovanni, Dauriz, Marco, Laroche, Cécile, Temporelli, Pier Luigi, Hassanein, Mahmoud, Seferovic, Petar M., Drozdz, Jaroslaw, Ferrari, Roberto +9 more·2017·European Journal of Heart Failure

Abstract

Aims: The aim of this study was to evaluate the in-hospital and 1-year prognostic impact of diabetes and elevated blood glucose levels at hospital admission in patients with acute heart failure (HF). Methods and results: We studied a multinational cohort of 6926 hospitalized patients with acute HF enrolled in the European Society of Cardiology (ESC) and Heart Failure Association (HFA) Long-Term Registry, of whom 49.4% (n = 3422) had known or previously undiagnosed diabetes (defined as self-reported history, or medication use, or fasting glucose levels ≥7.0 mmol/L or haemoglobin A1c ≥6.5%). Compared with those without diabetes, patients with known or previously undiagnosed diabetes had higher cumulative rates of in-hospital mortality, 1-year mortality, and 1-year HF re-hospitalization that occurred independently of multiple clinical risk factors: in-hospital mortality [6.8 vs. 4.4%; adjusted hazard ratio (HR) 1.774; 95% confidence interval (CI) 1.282–2.456, P < 0.001], 1-year all-cause mortality (27.5 vs. 24%; adjusted HR 1.162; 95% CI 1.020–1.325, P = 0.024), and 1-year hospital re-admissions for HF (23.2 vs. 18.5%; adjusted HR 1.320; 95% CI 1.139–1.530, P < 0.001). Moreover, elevated admission blood glucose concentrations were powerfully prognostic for in-hospital mortality, but not for 1-year mortality or re-hospitalizations, in both patients with and without diabetes. Conclusions: Among patients hospitalized for acute HF, the presence of diabetes is independently associated with an increased risk of in-hospital mortality, 1-year all-cause mortality, and 1-year re-hospitalizations for HF, underscoring the need for more effective and personalized treatments of diabetes in this particularly high-risk patient population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.679

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Targher, G., Dauriz, M., Laroche, C., Temporelli, P. L., Hassanein, M., Seferovic, P. M., Drozdz, J., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M. G., Mebazaa, A., Piepoli, M. F., Maggioni, A. P., Tavazzi, L., & ESC-HFA HF Long-Term Registry investigators
Affiliations
  • University of Verona (IT)
  • European Society of Cardiology (FR)
  • Fondazione Salvatore Maugeri (IT)
  • Alexandria University (EG)
  • Univerzitetski Klinički Centar Srbije (RS)
  • Department of Cardiology, Medical University , Lodz ,
  • University of Ferrara (IT)
  • Universitätsmedizin Göttingen (DE)
  • University of Warwick (GB)
  • Hospital Universitario 12 De Octubre (ES)
  • Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complexo Hospitalario, Universitario A Coruna , CHUAC, La Coruna ,
  • Inserm (FR)
  • Guglielmo da Saliceto Hospital (IT)
  • Maria Cecilia Hospital (IT)
Corresponding author
Maggioni, Aldo Pietro
Venue
European Journal of Heart Failure
Published
2016-10-28
Volume
19
Issue
1
Pages
54-65
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2541827286
Cited by
169
References
27
Citations by year
2026: 8 · 2025: 9 · 2024: 16 · 2023: 24 · 2022: 14 · 2021: 18 · 2020: 22 · 2019: 19 · 2018: 20 · 2017: 17 · 2016: 2
FWCI
15.96
Type
journal article
Language
en
Open access
Locations
  • European Journal of Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • RUC (Universidade Da Coruña) (acceptedVersion, cc-by-nc-nd)
  • Monash University Research Portal (Monash University) (submittedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
Funders
  • Abbott Vascular Int. (2011–2014)
  • Amgen Cardiovascular (2012–2015)
  • AstraZeneca (2014–2017)
  • Bayer (2013–2018)
  • Boehringer Ingelheim (2013–2016)
  • Boston Scientific (2010–2012)
  • The Bristol Myers Squibb and Pfizer Alliance (2014–2016)
  • The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014–2017)
  • Edwards (2016–2019)
  • Gedeon Richter (2014–2017)
  • Menarini Int. Op. (2010–2012)
  • MSD-Merck & Co. (2011–2014)
  • Novartis Pharma AG (2014–2017)
  • ResMed (2014–2016)
  • Sanofi (2010–2011)
  • Servier (2012–2015)
  • Medtronic
  • Novartis
  • Boehringer-Ingelheim
  • Merck Serono
  • Irbtech
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes mellitus, acute heart failure, in-hospital mortality, one-year mortality, admission blood glucose, prognostic factors, undiagnosed diabetes
MeSH terms
Acute Disease, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Heart Failure, Humans, Hyperglycemia, Male, Middle Aged, Mortality, Patient Readmission, Prognosis, Registries, Cohort Studies, Proportional Hazards Models, Hospital Mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review